Literature DB >> 10867587

Assessing somatization in functional gastrointestinal disorders: integration of different criteria.

P Porcelli1, M De Carne, G A Fava.   

Abstract

BACKGROUND: Psychiatric assessment of somatization (the tendency to experience and communicate psychological distress in the form of physical symptoms and to seek medical help for them) currently rests on DSM criteria. An alternative diagnostic and conceptual framework has been proposed by an international group of psychosomatic investigators. The aim of this study was to compare these new criteria (Diagnostic Criteria for Psychosomatic Research, DCPR) with DSM-IV in a population where a high prevalence of psychosocial problems is expected (functional gastrointestinal disorders, FGID).
METHOD: One hundred and ninety consecutive patients with FGID in a tertiary care center were assessed according to DSM-IV and DCPR criteria.
RESULTS: The number of the 12 DCPR diagnoses was almost double that of DSM diagnoses. Only 9% of the patients were not identified by DCPR criteria, whereas this occurred in 25% of patients using DSM criteria. While patients who were given a DSM diagnosis frequently had additional DCPR diagnoses, many patients with DCPR syndromes did not fulfill any DSM criteria. Four DCPR syndromes appared to be particularly frequent and accounted for almost three quarters of the total diagnoses (alexithymia, persistent somatization, functional symptoms secondary to a psychiatric disorder, demoralization).
CONCLUSIONS: The joint use of DSM and DCPR criteria was found to improve the identification of psychological factors in FGID. The results may pave the way for changes in DSM classification of somatoform disorders. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2000        PMID: 10867587     DOI: 10.1159/000012394

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  8 in total

1.  Assessment of subclinical symptoms and psychological well-being in depression.

Authors:  G A Fava; L Mangelli
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001       Impact factor: 5.270

Review 2.  Criteria for psychosomatic research (DCPR) in the medical setting.

Authors:  Piero Porcelli; Chiara Rafanelli
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

3.  Comparison of dialectical behavior therapy and anti-anxiety medication on anxiety and digestive symptoms in patients with functional dyspepsia.

Authors:  Tahmine Tavakoli; Masoud Hoseini; Toktam Sadat Jafar Tabatabaee; Zeinab Rostami; Homa Mollaei; Afsane Bahrami; Sara Ayati; Bita Bijari
Journal:  J Res Med Sci       Date:  2020-06-30       Impact factor: 1.852

4.  Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome.

Authors:  Piero Portincasa; Antonio Moschetta; Giuseppe Baldassarre; Donato F Altomare; Giuseppe Palasciano
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

5.  The effectiveness of cognitive behavior stress management on functional dyspepsia symptoms.

Authors:  Zahra Dehghanizade; Yadolah Zargar; Mahnaz Mehrabizadeh Honarmand; Ahmad Kadkhodaie; Majid Eydi Baygi
Journal:  J Adv Med Educ Prof       Date:  2015-04

6.  Emotional Suppression and Oneiric Expression in Psychosomatic Disorders: Early Manifestations in Emerging Adulthood and Young Patients.

Authors:  Salvatore Settineri; Fabio Frisone; Angela Alibrandi; Emanuele Maria Merlo
Journal:  Front Psychol       Date:  2019-08-20

7.  Psychosomatic syndromes and anorexia nervosa.

Authors:  Giovanni Abbate-Daga; Nadia Delsedime; Barbara Nicotra; Cristina Giovannone; Enrica Marzola; Federico Amianto; Secondo Fassino
Journal:  BMC Psychiatry       Date:  2013-01-09       Impact factor: 3.630

8.  The clinical utility of a comprehensive psychosomatic assessment in the program for colorectal cancer prevention: a cross-sectional study.

Authors:  Sara Gostoli; Maria Montecchiarini; Alessia Urgese; Francesco Ferrara; Anna Maria Polifemo; Liza Ceroni; Asia Gasparri; Chiara Rafanelli; Vincenzo Cennamo
Journal:  Sci Rep       Date:  2021-08-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.